Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly- N -acetylglucosamine surface polysaccharide
- 1 May 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (18) , 7528-7533
- https://doi.org/10.1073/pnas.0700630104
Abstract
Poly-N-acetylglucosamine (PNAG) is a surface polysaccharide produced by Staphylococcus aureus and Staphylococcus epidermidis and is an effective target for opsonic and protective Ab for these two organisms. Recently, it has been found that Escherichia coli produces an exo-polysaccharide, designated polyglucosamine, that is biochemically indistinguishable from PNAG. We analyzed 30 E. coli strains isolated from urinary tract and neonatal bloodstream infections for the pga locus, PNAG antigen production, and susceptibility to opsonic killing and protection from lethal infection by Ab to PNAG. Twenty-six of 30 strains carried the pga locus, 25 of 30 expressed immunologically detectable PNAG, and 21 of 30 could be killed by rabbit IgG specific for the deacetylated form of the staphylococcal PNAG. Ab to staphylococcal PNAG protected mice against lethality from five different E. coli strains expressing PNAG. PNAG expression by both Gram-negative and Gram-positive organisms could make this antigen a conserved vaccine target for multiple pathogenic species of bacteria.Keywords
This publication has 38 references indexed in Scilit:
- Role of a Putative Polysaccharide Locus in Bordetella Biofilm DevelopmentJournal of Bacteriology, 2007
- Characterization of the Opsonic and Protective Activity against Staphylococcus aureus of Fully Human Monoclonal Antibodies Specific for the Bacterial Surface Polysaccharide Poly- N -AcetylglucosamineInfection and Immunity, 2006
- Comparative Opsonic and Protective Activities of Staphylococcus aureus Conjugate Vaccines Containing Native or Deacetylated Staphylococcal Poly- N -Acetyl-β-(1-6)-GlucosamineInfection and Immunity, 2005
- What's new in enteric infectious diseases at home and abroadCurrent Opinion in Infectious Diseases, 2005
- Poly- N -Acetylglucosamine Production in Staphylococcus aureus Is Essential for Virulence in Murine Models of Systemic InfectionInfection and Immunity, 2005
- Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and PreventionClinical Microbiology Reviews, 2005
- Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymeraseJournal of Antimicrobial Chemotherapy, 2005
- Escherichia coli: a growing problem in early onset neonatal sepsisAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2004
- Prevention and Cure of Systemic Escherichia coli K1 Infection by Modification of the Bacterial PhenotypeAntimicrobial Agents and Chemotherapy, 2004
- Molecular basis of intercellular adhesion in the biofilm‐forming Staphylococcus epidermidisMolecular Microbiology, 1996